Skip to main content
. 2023 Feb 2;7(15):3968–3977. doi: 10.1182/bloodadvances.2022008888

Table 1.

Overview of included patients according to aaIPI and first-line therapy

Number of patients R-ACVBP (n = 455) R-CHOP (n = 1304) R-CHOEP (n = 444)
aaIPI of 0 without bulk (n = 652)
 LNH03-1B 76
 FLYER 399
 MInT 58 55
 UNFOLDER 64
aaIPI of 1 (n = 924)
 LNH03-2B 134 134
 MInT 105 85
 UNFOLDER 466
aaIPI of 2-3 (n = 627)
 LNH03-3B 164
 LNH07-3B 81 78
 MegaCHOEP phase 2 47
 MegaCHOEP phase 3 189
 DENSE-R-MegaCHOEP 68

PET-guided trial.